The PurpleLab

sossa@publicize.co

News

Higher SARS-COV-2 spike antibody levels are associated with reduced risk of subsequent symptomatic and severe COVID-19. Jin, Yue; Yang, Fei; Rank, Christopher; Letovsky, Stanley; Ramge, Peter and Jochum, Simon from Roche Information Solutions, Roche Diagnostics GmbH, Roche Diagnostics Solutions, and Roche Diagnostics International presented a poster during ISPOR 2024. The objective was to assess the…

Articles

Creating a holistic direct to consumer (DTC) and healthcare provider (HCP) marketing strategy from scratch is a demanding task, especially if you don’t have the clinical expertise to precisely identify the consumers or providers you should be targeting. We’re here to give you 5 simple steps to creating a holistic DTC and HCP targeting strategy…

Videos

The Skinny on Weight loss Drugs This podcast was created in collaboration with the Pharmacy Podcast Network. PurpleLab’s dataset from October 2022 – October 2023 shows that 2.8M people had been prescribed and dispensed a semaglutide drug.  PurpelLab’s database shows who really is getting access to the drugs by looking into:  States with most prescriptions (and zoom…

Solution Sheets

Standardized pricing imputes proxy costs that provide parity across data sources to determine healthcare costs. This allows you to facilitate nationwide studies of healthcare utilization and comparative analyses using the adjusted price, geographically adjusted price, and line of business adjusted price for services. Life Sciences Download Let’s Talk! Previous Next

Articles

PurpleLab was selected to present a poster at PMSA 2024 on imputing SDOH information on pharmacy claims. This study was centered around prescription fill rates of Semaglutides in the adolescent population. In December of 2022, the FDA approved adolescents BMI at or above the 95th percentile eligible for a Semaglutide prescription. PurpleLab used a combination…

Articles

A large CRO has incorporated PurpleLab data directly into their workflow to support all therapeutic areas and phases of clinical trial work from RWE and pre-award through phase IV and beyond including market access and HEOR work. This strategy has been incorporated for all of their clients.  “The data and services provided by PurpleLab have…

Articles

Payers are continuously looking to improve health outcomes. Removing barriers to care and improving care access through analyzing social determinants of health (SDOH) data is a key strategy. The social determinants of health (SDOH) include education, housing, transportation, income as well as other factors including where people are born, raised, live and work that impact their…

Articles

Semaglutide has gone viral. Ozempic and other glucagon-like peptide-1 (GLP-1) receptor agonists are so popular that more than 24 million Americans—about 7% of the population—could be taking them for weight loss by 2035, according to the latest estimates. The medications have been hailed as “a significant leap forward in tackling obesity,” which affects 41.9% of…

Articles

This blog is part two in a series exploring the use of real-world evidence to produce meaningful insights in clinical pharma.  Pharmaceutical manufacturers do more than just produce medications that line pharmacy and hospital shelves: they also need to closely observe and respond to market conditions, changing clinical guidelines, and safety regulations, to ensure that…

Articles

This blog is part one in a series exploring the use of real-world evidence to produce meaningful insights in clinical pharma.  Clinical trials are crucial for developing new medications and treatments, but they require meticulous pre-planning and feasibility assessments, which can be extremely time-consuming. Real-world evidence (RWE) offers a promising solution to expedite this process….